OverviewChartNews

CAC ALL-TRADABLE/  FR0003999499  

2024-04-19 6:00:00 PM Chg. -4.16 Open High Low Previous Close
5,928.16XXP -0.07% 5,890.50 5,939.71 5,874.63 5,932.32
GlobeNewswire 03-11 PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares fr...
GlobeNewswire 02-20 PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nas...
GlobeNewswire 01-18 PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2...
GlobeNewswire 01-09 LECTRA: Lectra announces the acquisition of the majority of the capital of Launchmetrics
GlobeNewswire 2023-11-14 PHAXIAM Provides Business and Financial Update for the Third Quarter of 2023
GlobeNewswire 2023-10-24 PHAXIAM Therapeutics obtains authorizations to launch its phase 1 study in endocarditis infections c...
GlobeNewswire 2023-10-23 TP ICAP Midcap initiates coverage of PHAXIAM Therapeutics with a “Buy” recommendation
GlobeNewswire 2023-10-09 PHAXIAM Therapeutics announces high coverage performance of its two anti-Staphylococcus aureus phage...
GlobeNewswire 2023-10-04 PHAXIAM Receives Compliance Notice from Nasdaq
GlobeNewswire 2023-10-03 PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaboration
GlobeNewswire 2023-09-21 PHAXIAM Provides Business and Financial Update For the First Half of 2023
GlobeNewswire 2023-09-19 PHAXIAM Therapeutics extends its phage portfolio to Klebsiella pneumoniae, a new resistant and aggre...
GlobeNewswire 2023-09-18 PHAXIAM Therapeutics announces the completion of its reverse share split
GlobeNewswire 2023-09-05 PHAXIAM Therapeutics publishes its cash position and new financial calendar, and announces its parti...
GlobeNewswire 2022-03-28 ERYTECH to Participate in the Upcoming April Investor Conferences
GlobeNewswire 2022-03-28 Sword Group: INFORMATION ON THE NUMBER OF SHARES AND VOTING RIGHTS AT 28/02/2022
GlobeNewswire 2022-03-11 ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2021
GlobeNewswire 2022-02-08 ERYTECH Expands Patent Portfolio for the Treatment of Rare Metabolic Diseases
GlobeNewswire 2022-01-24 ERYTECH Announces Presentation of Results of Two Clinical Trials of Eryaspase in Pancreatic Cancer...
GlobeNewswire 2022-01-03 ERYTECH to Participate in the Upcoming January Virtual Investor Conferences
GlobeNewswire 2021-12-14 ERYTECH Announces $7.85 Million Registered Direct Offering
GlobeNewswire 2021-12-13 ERYTECH Announces Presentation of Results of Expanded Access Program in ALL at 2021 ASH Annual Meeti...
GlobeNewswire 2021-11-29 ERYTECH Secures US Patent Directed to Sequential Use of Methioninase & Asparaginase against Solid Tu...
GlobeNewswire 2021-11-15 ERYTECH Provides Business and Financial Update for the Third Quarter of 2021
GlobeNewswire 2021-11-15 ERYTECH Announces Upcoming Poster Presentation at the 2021 American Society of Hematology Annual Mee...